At a Glance
- Tasks: Lead innovative oncology programmes and drive impactful clinical development strategies.
- Company: Join GSK, a global biopharma leader committed to transforming health outcomes.
- Benefits: Enjoy a hybrid work model, competitive salary, and a culture that values diversity.
- Other info: Be part of a team that aims to positively impact 2.5 billion lives by 2030.
- Why this job: Make a real difference in cancer care while working with cutting-edge science and technology.
- Qualifications: Experience in oncology drug development and strong leadership skills required.
The predicted salary is between 80000 - 90000 £ per year.
This job is with GSK, an inclusive employer. At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people's lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing.
Overview
Cancer is unrelenting, but so are we. At GSK, we are committed to transforming outcomes for people with cancer through innovative science, bold ambition, and strong partnerships across the healthcare ecosystem. We focus our science where it can matter most - advancing care in cancers with high unmet need, grounded in a deep understanding of disease biology and deliberate scientific choices that connect discovery to meaningful impact in the real world.
The Portfolio Integration Lead (PIL) is a senior role in Oncology Clinical Development, responsible for shaping the advancement of multiple oncology programmes from our portfolio with a focus on particular cancers. Working closely with both the VP and Clinical Development Leads (CDLs) and cross-functional teams across GSK, this role ensures scientific alignment, portfolio coherence, and development excellence across assets.
In This Role You Will:
- Provide senior scientific partnership to CDLs, particularly in areas such as disease biology, biomarker strategy, and novel treatment combinations development.
- Ensure consistent cross-programme ways of working to improve development efficiency and execution.
- Drive cross-programme portfolio working groups and ensure business level alignment.
- Drive and support clinical trial innovation based on evolving oncology treatment landscape, government regulations, basic/translational science, and emerging technologies.
- Strengthen the scientific and strategic positioning of a pan-asset portfolio across multiple clinical and pre-clinical assets.
- Drive initiatives that advance data and technology strategies supporting development decision-making.
- Shape engagement with external experts and governance bodies including advisory boards where relevant.
Key Responsibilities
- Shape the advancement of multiple development programs within the oncology portfolio by providing scientific insights across assets.
- Prepare detailed strategic analyses and portfolio recommendations on behalf of the Disease Area Vice President.
- Ensure alignment and coordination across Clinical Matrix Teams (CMTs) and relevant cross-functional stakeholders.
- Drive disease-level strategic discussions and portfolio planning.
- Serve as a subject matter expert supporting global health authority interactions, regulatory submissions and key development milestones.
Partnership with Clinical Development Leads
- Serve as a scientific thought partner to CDLs across multiple asset programs.
- Shape key aspects of clinical development strategy for a given tumour types.
Clinical Development Excellence
- Establish and champion consistent ways of working across programs to improve efficiency and development quality.
- Drive innovation in clinical development approaches for a given disease area.
External Scientific Engagement
- Maintain a deep understanding of the evolving tumour disease landscape, standards of care, and emerging science.
- Shape engagement with external experts through advisory boards.
Data & Innovation Strategy
- Drive initiatives that strengthen the application of data, technology, and analytics in clinical development decision-making.
- Champion innovative approaches to clinical trials and portfolio insights.
Basic Qualifications:
- Bachelor's / Master's / Advanced degree in a scientific or medical discipline.
- Experience in oncology drug development within pharmaceutical or biotechnology environments.
- Experience of clinical development processes, regulatory pathways, and oncology therapeutic landscapes.
- Experience in operating structured matrix organizations.
Preferred Qualifications:
- Experience as a Clinical Development Lead, Medical Director, Clinical Scientist Program Lead, or equivalent program leadership role in oncology.
- Expertise in biomarker development, precision medicine strategies, or combination therapy approaches.
- Experience engaging with external scientific experts, advisory groups, and Health Authorities.
- Demonstrated ability to influence senior stakeholders and shape strategic portfolio discussions.
- Familiarity with clinical trial innovation methods.
Work Arrangement: This role offers a hybrid working model, with a mix of on-site and remote work.
Why GSK? GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how we deliver for patients, shareholders and our people.
GSK is an Equal Opportunity Employer.
